News
MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
Schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) are among the world’s most persistent neglected tropical diseases (NTDs) — a group of conditions that disproportionately affect the world ...
Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad.
Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib missed the mark in two phase 3 trials, spelling the end of the programme ...
Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertiseVANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- ...
Infants of mothers treated in the first trimester with TMP-SMX appeared to have a higher risk for any malformation than those ...
6d
Irish Examiner on MSNTrump’s tariff threat to pharma in Ireland is leading to a push for trade unionsUnion momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...
Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with ...
1d
Medpage Today on MSNFirst-Trimester UTI Antibiotic Use Tied to Congenital Malformation RisksThe primary exposure was a first-trimester prescription fill of nitrofurantoin, TMP-SMX, fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin), and β-lactams to treat UTI. Any congenital ...
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
1d
The Healthy @Reader's Digest on MSNThe 9 Healthiest Nuts Worth Eating, from Leading Clinical Nutrition ProsJulia Zumpano, RD, LD, has been a registered dietician at the Cleveland Clinic Center for Human Nutrition for almost 20 years ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results